| Parameters | Stemnovate’s enzymatic DNA synthesis platform | Chemical DNA synthesis and Centralized services |
|---|---|---|
| Length | ETFDS is capable of generating short to long to ultra-long DNA | Phosphoramidite synthetic DNA is limited to < 150mers for a polynucleotide strand. |
| Quality | High quality with low impurities | Level of impurities increases as DNA length exceeds >150mers |
| Synthesis Method | Uses natural enzymes in aqueous solution. | Uses harsh environmentally unfriendly chemicals |
The DNA synthesis has potential to revolutionise the field of drug discovery, biotechnology
and nanotechnology.
Drug discovery
The applications are varied such as RNA therapy, antibody research, Vaccine development.
Biotechnology
The drug bio-production, biofuel research, crop production and research for food security.
Nanotechnology
DNA synthesis is being explored for novel DNA data storage and nano-material discoveries.
Induced Pluripotent stem cell lines
Human & Multispecies Primary cells
Cell culture & analysis package
ServicesCell Reprogramming
Cell Differentiation
Application Development
DataPharmacogenomic Data
Single Nucleotide Polymorphism
Transcriptomics
Pharmacokinetic/Pharmacodynamic Data
DeviceMicrophysiological systems
Microfluidic design, prototyping and manufacturing
Biosensing and Automation
Our clients say
You are doing some amazing and important work at Stemnovate, we are happy to be associated with your project.“
Thank you for your presentations, they were really great and stimulating. I am very happy we met and that we could get the cells in culture!“
CASE STUDIES & Partnership
Stemnovate is partnering up with the world renowned Roslin Institute on a project to create in vitro modelling systems for muscular studies that can help make new discoveries for better animal health and production.
Prof Ciro Semprebon will be working in partnership with Stemnovate on the prestigious EPSRC grant project for advancing SLIPS technology.